The Yellowstone National Park is one of the most popular destinations for tourists and locals in the US. It’s also a dormant super volcano that has terrifying destructive potential if it erupts. While the chances of this happening over the next few years might be remote, NASA is not taking any chances. That’s why it wants to spend about $3.46 billion to turn it into a geothermal energy source.
The government space agency actually revealed these details after a BBC coverage of super volcanoes came out. Shortly after, NASA researchers, including Brian Wilcox, contacted the publication to share information regarding plans that they have to deal with the possibility of an eruption in Yellowstone. While the plan may be expensive, it does come with several advantages that might just convince politicians of its worth.
“Yellowstone currently leaks around 6GW in heat,” Wilcox told the publication. “Through drilling in this way, it could be used to create a geothermal plant, which generates electric power at extremely competitive prices of around $0.10/kWh. You would have to give the geothermal companies incentives to drill somewhat deeper and use hotter water than they usually would, but you would pay back your initial investment, and get electricity which can power the surrounding area for a period of potentially tens of thousands of years. And the long-term benefit is that you prevent a future supervolcano eruption which would devastate humanity.”
NASA would basically drill into the lower sides of the volcano, which is outside the boundaries of the park, Futurism reports. From there, pipes would be inserted where water would be pumped into the volcano. The resulting steam would then create pressure, which is what will allow the researchers to harvest energy from the volcano. It basically removes the factor that would lead to an explosion.


Neuralink Expands Brain Implant Trials with 12 Global Patients
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Tabletop particle accelerator could transform medicine and materials science
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Lab-grown meat: you may find it icky, but it could drive forward medical research
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 



